To evaluate costs, benefits and cost-effectiveness of anti-TNF agents in PsA patients with inadequate response to conventional treatment.
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy / Olivieri, I., De Portu, S., Salvarani, C., Cauli, A., Lubrano, E., Spadaro, A., Cantini, F., Cutro, M.S., Mathieu, A., Matucci Cerinic, M., Pappone, N., Punzi, L., Scarpa, R., Mantovani, L.G.. - In: RHEUMATOLOGY. - ISSN 1462-0332. - 47:11(2008), pp. 1664-1670. [10.1093/rheumatology/ken320]
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy
SALVARANI, CARLO;
2008
Abstract
To evaluate costs, benefits and cost-effectiveness of anti-TNF agents in PsA patients with inadequate response to conventional treatment.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
